Johnson & Johnson (JNJ)
149.12
+1.21
(+0.82%)
USD |
NYSE |
Apr 22, 16:00
149.69
+0.57
(+0.38%)
After-Hours: 20:00
Johnson & Johnson Cash from Operations (TTM): 22.79B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 22.79B |
September 30, 2023 | 20.28B |
June 30, 2023 | 19.07B |
March 31, 2023 | 20.47B |
December 31, 2022 | 21.19B |
September 30, 2022 | 21.58B |
June 30, 2022 | 23.58B |
March 31, 2022 | 23.32B |
December 31, 2021 | 23.41B |
September 30, 2021 | 26.02B |
June 30, 2021 | 26.11B |
March 31, 2021 | 24.25B |
December 31, 2020 | 23.54B |
September 30, 2020 | 21.59B |
June 30, 2020 | 20.74B |
March 31, 2020 | 23.23B |
December 31, 2019 | 23.42B |
September 30, 2019 | 23.26B |
June 30, 2019 | 22.01B |
March 31, 2019 | 22.14B |
December 31, 2018 | 22.20B |
September 30, 2018 | 22.06B |
June 30, 2018 | 22.06B |
March 31, 2018 | 21.75B |
December 31, 2017 | 21.06B |
Date | Value |
---|---|
September 30, 2017 | 21.60B |
June 30, 2017 | 20.70B |
March 31, 2017 | 19.49B |
December 31, 2016 | 18.77B |
September 30, 2016 | 17.20B |
June 30, 2016 | 17.98B |
March 31, 2016 | 18.89B |
December 31, 2015 | 19.57B |
September 30, 2015 | 19.09B |
June 30, 2015 | 17.60B |
March 31, 2015 | 17.66B |
December 31, 2014 | 18.71B |
September 30, 2014 | 18.24B |
June 30, 2014 | 19.54B |
March 31, 2014 | 19.06B |
December 31, 2013 | 17.41B |
September 30, 2013 | 16.65B |
June 30, 2013 | 15.68B |
March 31, 2013 | 14.88B |
December 31, 2012 | 15.40B |
September 30, 2012 | 15.47B |
June 30, 2012 | 15.11B |
March 31, 2012 | 14.78B |
December 31, 2011 | 14.30B |
September 30, 2011 | 14.67B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
19.07B
Minimum
Jun 2023
26.11B
Maximum
Jun 2021
22.62B
Average
23.23B
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
Amgen Inc | 8.471B |
Gilead Sciences Inc | 8.006B |
Eli Lilly and Co | 4.240B |
Merck & Co Inc | 13.01B |
Shockwave Medical Inc | 196.05M |